3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Skin Neoplasms
2
Myelodysplastic Syndromes
2
Prostatic Neoplasms
1
Neoplasms
1
Myofibroma
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Intraocular Lymphoma
1
Inflammation
1
Hemorrhage
1
Eye Diseases
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Cytopenia
1
Corneal Endothelial Cell Loss
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Cataract
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Adenomyosis
1
Interventions
Nutrition Assessment
3
Exercise
3
Blood Pressure
3
Methods
2
Ethanol
2
Educational Status
2
Diet, Mediterranean
2
beta Carotene
1
Vitamin E
1
Standard of Care
1
Spironolactone
1
Simvastatin
1
Rosuvastatin Calcium
1
Restraint, Physical
1
Resistance Training
1
Referral and Consultation
1
Quality of Life
1
Pravastatin
1
Practice Guidelines as Topic
1
Positron-Emission Tomography
1
Physical Conditioning, Human
1
Patient Navigation
1
Nutritional Status
1
Metformin
1
Melatonin
1
Lysine Acetyltransferase 5
1
Jogging
1
Interviews as Topic
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
High-Intensity Interval Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Cardiovascular Diseases
×
Ascorbic Acid
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled